Calosyn Pharma
closedBiopharmaceutical company developing therapeutics for osteoarthritis.
Launch date
Employees
Market cap
-
Enterprise valuation
€1—2m (Dealroom.co estimates Feb 2012.)
Atlanta Georgia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$400k | Seed | ||
N/A | $1.9m | Early VC | |
N/A | $310k | Early VC | |
* | N/A | $750k | Debt |
Total Funding | €2.4m |
Recent News about Calosyn Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.